Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05980312 · ClinicalTrials.gov registry record · NA
Does Early Elbow Motion Improve Patient Outcomes After Surgically Treated Elbow Fractures?
A NA study, sponsored by The Cooper Health System.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05980312 is a NA study that has completed, run by The Cooper Health System. The registered enrollment target is 80 participants.
The verdict
NCT05980312, a NA study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy, defined as improved range of motion and functional outcome scores, of early elbow motion in the early (immediately post-op) and late postoperative periods (2 week post-op).
Interventions
- OTHER Splint Immobilization
- OTHER Early Motion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-12-27 |
| Est. Completion | 2023-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05980312
The ClinicalTrials.gov registry entry for NCT05980312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Splint Immobilization is the first listed.
NCT05980312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05980312 about?
NCT05980312 is a clinical study titled "Does Early Elbow Motion Improve Patient Outcomes After Surgically Treated Elbow Fractures?". The purpose of this study is to compare the safety and efficacy, defined as improved range of motion and functional outcome scores, of early elbow motion in the early (immediately post-op) and late postoperative periods (2 week post-op).
What is the current status of trial NCT05980312?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-12-27. Estimated completion is 2023-04-20.
What interventions are being tested in trial NCT05980312?
The interventions under investigation include: Splint Immobilization (OTHER), Early Motion (OTHER).
Who is sponsoring clinical trial NCT05980312?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.